imatinib mesylate has been researched along with Cherubism in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akagi, T; Hiramatsu Asano, S; Iseki, M; Ishihara, K; Kittaka, M; Morita, Y; Mukai, T; Ono, M; Oohashi, T; Tosa, I; Ueki, Y; Yahagi, A | 1 |
| Blatt, J; Fan, Z; Foreman, AKM; McKay, C; Padilla, RJ; Tallent, B | 1 |
| Eiden, S; Lausch, E; Meckel, S | 1 |
| Ahson, I; Ricalde, P; Schaefer, ST | 1 |
4 other study(ies) available for imatinib mesylate and Cherubism
| Article | Year |
|---|---|
Imatinib has minimal effects on inflammatory and osteopenic phenotypes in a murine cherubism model.
Topics: Adaptor Proteins, Signal Transducing; Animals; Bone Diseases, Metabolic; Cherubism; Imatinib Mesylate; Inflammation; Mice; Phenotype; Tumor Necrosis Factor-alpha | 2023 |
Response of Central Giant Cell Granuloma of the Jaw to Imatinib.
Topics: Cherubism; Child; Diagnosis, Differential; Granuloma, Giant Cell; Humans; Imatinib Mesylate; Tomography, X-Ray Computed | 2023 |
Topics: Cherubism; Child, Preschool; Diagnosis, Differential; Drug Monitoring; Humans; Imatinib Mesylate; Magnetic Resonance Imaging; Male; Protein Kinase Inhibitors; Treatment Outcome | 2017 |
A Paradigm Shift in the Management of Cherubism? A Preliminary Report Using Imatinib.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Cherubism; Child; Child, Preschool; Humans; Imatinib Mesylate; Mandible; Maxilla; Tooth | 2019 |